Clinical Trials Browser

Interventional × Diarrhea × Breast × Clear all

NCT04038619 2026-03-20

Fecal Microbiota Transplantation in Treating Immune-Checkpoint Inhibitor Induced-Diarrhea or Colitis in Genitourinary Cancer Patients

Phase 1 Recruiting

BreastDermatologicGynecologicThoracic

Breast Neoplasms, Uterine Cervical Neoplasms, Colitis, Diarrhea, Lung Neoplasms, Melanoma, Ovarian Neoplasms, Urogenital Neoplasms, Uterine Neoplasms

NCT06892093 2025-09-08

Probiotics for Prevention of Neratinib-Induced Diarrhea in Breast Cancer Patients

Phase NA Recruiting

Breast Neoplasms, Diarrhea

NCT06152471 2023-11-30

ASF-BC

Phase 3 Unknown

Breast Neoplasms, Diarrhea, Drug-Related Side Effects and Adverse Reactions

NCT04736186 2021-02-03

Prevention and Treatment of Pyrrolitinib-associated Diarrhea

Phase 2/3 Unknown

Breast Neoplasms, Diarrhea

NCT02294786 2019-07-15

Study of Prophylactic Octreotide to Prevent or Reduce the Frequency and Severity of Diarrhoea in Subjects Receiving Lapatinib With Capecitabine for the Treatment of Metastatic Breast Cancer

Phase 2 Terminated

62 enrolled 25 charts

Breast Neoplasms, Diarrhea, Neoplasms